LATEST NEWS

The Effect of Udenafil on Heart Rate and Blood Pressure in Adolescents With the Fontan Circulation - ScienceDirect

LATEST NEWS

Mezzion Pharma Raises Nearly $40M to Advance a First-to-Market Treatment Option for Fontan Patients

LATEST NEWS

Mezzion Pharma Submits Protocol for Confirmatory Pivotal Phase 3 Trial ("FUEL-2") in Fontan Subjects